天益医疗
(301097)
| 流通市值：6.96亿 | | | 总市值：22.37亿 |
| 流通股本：1834.74万 | | | 总股本：5894.74万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 589,291,668.04 | 407,228,869.75 | 433,784,894.37 | 671,184,494.14 |
| 应收票据及应收账款 | 36,720,727.84 | 50,105,924.77 | 50,749,972.57 | 58,563,321.26 |
| 应收账款 | 36,720,727.84 | 50,105,924.77 | 50,749,972.57 | 58,563,321.26 |
| 预付款项 | 15,305,957.9 | 8,034,588.15 | 11,305,490.97 | 8,616,191.1 |
| 其他应收款合计 | 14,642,993.84 | 14,749,114.86 | 3,570,231.9 | 4,212,705.16 |
| 存货 | 85,709,970.06 | 86,799,967.45 | 77,345,067.91 | 83,882,866.47 |
| 合同资产 | 8,553.04 | 19,372.96 | - | - |
| 其他流动资产 | 25,704,288.34 | 24,868,074.02 | 21,023,159.61 | 18,135,734.03 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 937,961,788.83 | 922,876,080.02 | 925,720,525.3 | 1,012,742,740.09 |
| 非流动资产: | | | | |
| 长期股权投资 | 83,980,864.37 | 84,489,259.04 | 85,524,211.91 | 26,242,480.11 |
| 其他非流动金融资产 | 38,171,629.18 | 23,171,629.18 | 24,000,000 | 24,000,000 |
| 投资性房地产 | 2,440,568.46 | 2,491,191.63 | 8,762,350.71 | 2,592,437.97 |
| 固定资产 | 390,695,143.75 | 395,027,933.18 | 279,832,252.48 | 277,284,171.32 |
| 在建工程 | 234,340,527.27 | 233,816,711.93 | 266,393,094.66 | 254,736,279.15 |
| 使用权资产 | 4,464,348.8 | 4,671,828.2 | 4,999,111.88 | 5,147,083.67 |
| 无形资产 | 101,171,448.09 | 101,571,057.35 | 74,246,900.72 | 74,756,505.47 |
| 长期待摊费用 | 11,402,818.43 | 11,313,000.38 | 22,142,823.84 | 11,887,759.04 |
| 递延所得税资产 | 5,659,435.98 | 3,389,630.49 | 3,097,440.41 | 2,678,829.99 |
| 其他非流动资产 | 34,964,044.89 | 11,971,914.84 | 17,094,041.07 | 34,671,639.15 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 907,290,829.22 | 871,914,156.22 | 786,092,227.68 | 713,997,185.87 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,845,252,618.05 | 1,794,790,236.24 | 1,711,812,752.98 | 1,726,739,925.96 |
| 流动负债: | | | | |
| 短期借款 | 62,035,322.23 | 50,042,594.45 | 70,047,247.22 | 99,078,611.11 |
| 交易性金融负债 | 418,481.95 | 1,156,276.95 | 4,869,007.47 | 1,353,291.08 |
| 应付票据及应付账款 | 93,456,444.21 | 132,124,991.57 | 73,074,505.4 | 86,147,102.04 |
| 应付账款 | 93,456,444.21 | 132,124,991.57 | 73,074,505.4 | 86,147,102.04 |
| 预收款项 | - | - | 127,890 | - |
| 合同负债 | 16,106,598.54 | 7,725,533.51 | 7,788,115.47 | 6,775,049.9 |
| 应付职工薪酬 | 12,988,105.4 | 27,203,007.19 | 20,304,528.43 | 17,253,365.98 |
| 应交税费 | 4,743,614.36 | 4,678,194.96 | 3,450,783.81 | 3,572,495.14 |
| 其他应付款合计 | 24,011,558.88 | 25,454,221.15 | 662,591.5 | 770,057.39 |
| 一年内到期的非流动负债 | 80,171,980.63 | 109,740,807.36 | 59,233,321.59 | 49,685,309.34 |
| 其他流动负债 | 1,632,813.48 | 4,189,659.18 | 904,140.49 | 870,644.56 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 295,564,919.68 | 362,315,286.32 | 240,462,131.38 | 265,505,926.54 |
| 非流动负债: | | | | |
| 长期借款 | 327,530,648.38 | 228,321,712.64 | 259,051,900 | 238,740,298.89 |
| 租赁负债 | 3,855,564.58 | 4,104,596.19 | 4,433,283.26 | 4,676,344.15 |
| 递延收益 | 23,862,961.81 | 7,205,621.55 | 7,372,960.29 | 7,552,445.41 |
| 递延所得税负债 | 317,410.96 | 508,890.41 | - | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 355,566,585.73 | 240,140,820.79 | 270,858,143.55 | 250,969,088.45 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 651,131,505.41 | 602,456,107.11 | 511,320,274.93 | 516,475,014.99 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 58,947,368 | 58,947,368 | 58,947,368 | 58,947,368 |
| 资本公积 | 791,983,563.39 | 795,860,105.76 | 794,317,284.39 | 793,393,386.97 |
| 减:库存股 | 57,656,365.3 | 57,656,365.3 | 57,641,335.95 | 56,983,689.95 |
| 其他综合收益 | 879,846.32 | -1,243,562.91 | -994,541.82 | -1,381,010.63 |
| 盈余公积 | 29,473,684 | 29,473,684 | 29,473,684 | 29,473,684 |
| 未分配利润 | 370,493,016.23 | 361,740,355.2 | 368,826,905.45 | 377,125,483.05 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,194,121,112.64 | 1,187,121,584.75 | 1,192,929,364.07 | 1,200,575,221.44 |
| 少数股东权益 | - | 5,212,544.38 | 7,563,113.98 | 9,689,689.53 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,194,121,112.64 | 1,192,334,129.13 | 1,200,492,478.05 | 1,210,264,910.97 |
| 负债和股东权益合计 | 1,845,252,618.05 | 1,794,790,236.24 | 1,711,812,752.98 | 1,726,739,925.96 |
| 公告日期 | 2025-04-28 | 2025-04-15 | 2024-10-28 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |